je.st
news
Home › commercialize
Tag: commercialize
The Medicines Company And Alnylam Form Strategic Alliance To Develop And Commercialize RNAi Therapeutics Targeting PCSK9 For The Treatment Of Hypercholesterolemia
2013-02-04 07:00:00| drugdiscoveryonline News Articles
The Medicines Company and Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced recently that they have formed an exclusive global alliance for the development and commercialization of Alnylam’s ALN-PCS RNAi therapeutic program for the treatment of hypercholesterolemia
Sites : [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19]